New Drug Applications U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb’s Application for CC-486 for Maintenance Treatment of Adult Patients in Remission with Acute Myeloid Leukemia 5 years ago
New Drugs FDA Approves Tabrecta (capmatinib) for Metastatic Non-Small Cell Lung Cancer with METex14 5 years ago
Healthcare News Pro Wrestler Caprice Coleman Offers Advice On How To Stay Fit And Motivated At Home 5 years ago
Pharma Industry News US OK’s AZ’ Farxiga for heart failure with reduced ejection fraction 5 years ago